These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
84 related articles for article (PubMed ID: 11436038)
41. Thrombin induces the release of angiopoietin-1 from platelets. Li JJ; Huang YQ; Basch R; Karpatkin S Thromb Haemost; 2001 Feb; 85(2):204-6. PubMed ID: 11246533 [TBL] [Abstract][Full Text] [Related]
42. [Morphology of changes in bronchial vessels in chronic inflammatory diseases of the lungs and their role in the development of pulmonary hypertension]. Kop'eva TN; Orazalieva AM; Biriukov IuV; Gudovskiĭ LM Probl Tuberk; 1993; (2):55-8. PubMed ID: 7984576 [TBL] [Abstract][Full Text] [Related]
43. Cyclooxygenase-2 expression in lung in patients with congenital heart malformations and pulmonary arterial hypertension. Loukanov T; Jaschinski C; Kirilov M; Klimpel H; Karck M; Gorenflo M Thorac Cardiovasc Surg; 2013 Jun; 61(4):307-11. PubMed ID: 23681850 [TBL] [Abstract][Full Text] [Related]
44. Alterations in extracellular matrix protein expression in neonatal pulmonary hypertension: implications for vascular function. Durmowicz AG; Stenmark KR J Perinatol; 1996; 16(2 Pt 2 Su):S11-8. PubMed ID: 8732543 [No Abstract] [Full Text] [Related]
45. Induction of pulmonary hypertension by an angiopoietin 1/TIE2/serotonin pathway. Sullivan CC; Du L; Chu D; Cho AJ; Kido M; Wolf PL; Jamieson SW; Thistlethwaite PA Proc Natl Acad Sci U S A; 2003 Oct; 100(21):12331-6. PubMed ID: 14512515 [TBL] [Abstract][Full Text] [Related]
46. [Progesterone metabolism in pulmonary hypertension patients with chronic nonspecific lung diseases]. Pribylova NN Vrach Delo; 1982 Nov; (11):51-3. PubMed ID: 7157759 [No Abstract] [Full Text] [Related]
47. Chemokine macrophage inflammatory protein-1alpha mRNA expression in lung biopsy specimens of primary pulmonary hypertension. Fartoukh M; Emilie D; Le Gall C; Monti G; Simonneau G; Humbert M Chest; 1998 Jul; 114(1 Suppl):50S-51S. PubMed ID: 9676626 [No Abstract] [Full Text] [Related]
48. [Serotonin metabolism and pulmonary hypertension in chronic lung diseases]. Pribilova NN Sov Med; 1976 Dec; (12):107-11. PubMed ID: 1013779 [No Abstract] [Full Text] [Related]
49. The angiogenic gene profile of pulmonary endarterectomy specimens: Initial study. Ermerak NO; Yilmaz B; Batirel S; Olgun Yildizeli S; Kocakaya D; Mutlu B; Tas S; Yildizeli B JTCVS Open; 2023 Mar; 13():423-434. PubMed ID: 37063122 [TBL] [Abstract][Full Text] [Related]
50. The problem of medial hypertrophy in pulmonary hypertension. SHORT DS Med Thorac; 1962; 19():411-7. PubMed ID: 13988673 [No Abstract] [Full Text] [Related]
52. CHANGES IN PULMONARY VASCULATURE IN LUNG DISEASES WHICH LEAD TO PULMONARY HYPERTENSION. Batra RB; Basu SK Med J Armed Forces India; 1997 Oct; 53(4):282-286. PubMed ID: 28769513 [TBL] [Abstract][Full Text] [Related]
53. Mechanisms involved in the production of pulmonary hypertension. SPAIN DM N Y State J Med; 1951 Aug; 51(16):1903-7. PubMed ID: 14863618 [No Abstract] [Full Text] [Related]
54. [Combat pulmonary hypertension: long march, difficulty but successful ultimate destination]. Jing ZC; Xu XQ Zhonghua Nei Ke Za Zhi; 2013 Aug; 52(8):628-30. PubMed ID: 24199873 [No Abstract] [Full Text] [Related]
55. Slide-Seq for Spatially Mapping Gene Expression. Metabolic Syndrome Exacerbates Group 2 Pulmonary Hypertension, and NAD Metabolism Is Influenced by Tissue Origin. Chelvanambi S; Hester JM; Sharma S; Lahm T; Frump AL Am J Respir Cell Mol Biol; 2020 Jan; 62(1):112-114. PubMed ID: 31633380 [No Abstract] [Full Text] [Related]
56. Do shoot the messenger: Taking aim at RNA to treat genetic skin disorders. van Steensel MA Exp Dermatol; 2017 Jan; 26(1):22-23. PubMed ID: 27717021 [No Abstract] [Full Text] [Related]